Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Mammalian Cell Line Development Market 2025 by Company, Regions, Type and Application, Forecast to 2031

  • RnM4662487
    • |
  • 31 December, 2025
    • |
  • Global
    • |
  • 152 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our latest research, the global Mammalian Cell Line Development market size will reach USD 487 million in 2031, growing at a CAGR of 9.3% over the analysis period.
Mammalian cell line development refers to the process of creating and optimizing cell lines derived from mammalian species, such as humans, mice, or monkeys, for use in research, biopharmaceutical production, and other applications. This involves selecting a suitable cell type, establishing a stable cell line, and optimizing growth conditions to ensure high productivity and consistency. Mammalian cell lines are commonly used in the production of recombinant proteins, monoclonal antibodies, and vaccines, as they closely mimic the physiology and function of human cells, making them valuable tools for studying disease mechanisms and developing new therapies. The development of mammalian cell lines is a crucial step in biotechnology and biomedical research, enabling the production of complex biological molecules and advancing our understanding of human health and disease.

This report is a detailed and comprehensive analysis for global Mammalian Cell Line Development market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Mammalian Cell Line Development market size and forecasts, in consumption value ($ Million), 2020-2031
Global Mammalian Cell Line Development market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Mammalian Cell Line Development market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Mammalian Cell Line Development market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mammalian Cell Line Development
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mammalian Cell Line Development market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, AGC Biologics, Sigma-Aldrich, Fraunhofer, Cytena, GTP Bioways, KBI Biopharma, Lonza, Abzena, FUJIFILM Diosynth Biotechnologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Mammalian Cell Line Development market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
CHO (Chinese Hamster Ovary) Cells
HEK (Human Embryonic Kidney) Cells
NS0 (Mouse Myeloma) Cells
BHK (Baby Hamster Kidney) Cells
Others
Market segment by Application
Biopharmaceutical Production
Drug Discovery and Development
Toxicity Testing
Others
Market segment by players, this report covers
Thermo Fisher Scientific
AGC Biologics
Sigma-Aldrich
Fraunhofer
Cytena
GTP Bioways
KBI Biopharma
Lonza
Abzena
FUJIFILM Diosynth Biotechnologies
Hera
WuXi Biologics
Danaher
Northway Biotech
Sartorius
EirGenix
Tanvex
Menarini Biotech
FyoniBio
Creative Biogene
Rodon Biologics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Mammalian Cell Line Development product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Mammalian Cell Line Development, with revenue, gross margin, and global market share of Mammalian Cell Line Development from 2020 to 2025.
Chapter 3, the Mammalian Cell Line Development competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Mammalian Cell Line Development market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Mammalian Cell Line Development.
Chapter 13, to describe Mammalian Cell Line Development research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Mammalian Cell Line Development by Type
    • 1.3.1 Overview: Global Mammalian Cell Line Development Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Mammalian Cell Line Development Consumption Value Market Share by Type in 2024
    • 1.3.3 CHO (Chinese Hamster Ovary) Cells
    • 1.3.4 HEK (Human Embryonic Kidney) Cells
    • 1.3.5 NS0 (Mouse Myeloma) Cells
    • 1.3.6 BHK (Baby Hamster Kidney) Cells
    • 1.3.7 Others
  • 1.4 Global Mammalian Cell Line Development Market by Application
    • 1.4.1 Overview: Global Mammalian Cell Line Development Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Biopharmaceutical Production
    • 1.4.3 Drug Discovery and Development
    • 1.4.4 Toxicity Testing
    • 1.4.5 Others
  • 1.5 Global Mammalian Cell Line Development Market Size & Forecast
  • 1.6 Global Mammalian Cell Line Development Market Size and Forecast by Region
    • 1.6.1 Global Mammalian Cell Line Development Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Mammalian Cell Line Development Market Size by Region, (2020-2031)
    • 1.6.3 North America Mammalian Cell Line Development Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Mammalian Cell Line Development Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Mammalian Cell Line Development Market Size and Prospect (2020-2031)
    • 1.6.6 South America Mammalian Cell Line Development Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Mammalian Cell Line Development Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific Mammalian Cell Line Development Product and Solutions
    • 2.1.4 Thermo Fisher Scientific Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.2 AGC Biologics
    • 2.2.1 AGC Biologics Details
    • 2.2.2 AGC Biologics Major Business
    • 2.2.3 AGC Biologics Mammalian Cell Line Development Product and Solutions
    • 2.2.4 AGC Biologics Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 AGC Biologics Recent Developments and Future Plans
  • 2.3 Sigma-Aldrich
    • 2.3.1 Sigma-Aldrich Details
    • 2.3.2 Sigma-Aldrich Major Business
    • 2.3.3 Sigma-Aldrich Mammalian Cell Line Development Product and Solutions
    • 2.3.4 Sigma-Aldrich Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Sigma-Aldrich Recent Developments and Future Plans
  • 2.4 Fraunhofer
    • 2.4.1 Fraunhofer Details
    • 2.4.2 Fraunhofer Major Business
    • 2.4.3 Fraunhofer Mammalian Cell Line Development Product and Solutions
    • 2.4.4 Fraunhofer Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Fraunhofer Recent Developments and Future Plans
  • 2.5 Cytena
    • 2.5.1 Cytena Details
    • 2.5.2 Cytena Major Business
    • 2.5.3 Cytena Mammalian Cell Line Development Product and Solutions
    • 2.5.4 Cytena Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Cytena Recent Developments and Future Plans
  • 2.6 GTP Bioways
    • 2.6.1 GTP Bioways Details
    • 2.6.2 GTP Bioways Major Business
    • 2.6.3 GTP Bioways Mammalian Cell Line Development Product and Solutions
    • 2.6.4 GTP Bioways Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 GTP Bioways Recent Developments and Future Plans
  • 2.7 KBI Biopharma
    • 2.7.1 KBI Biopharma Details
    • 2.7.2 KBI Biopharma Major Business
    • 2.7.3 KBI Biopharma Mammalian Cell Line Development Product and Solutions
    • 2.7.4 KBI Biopharma Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 KBI Biopharma Recent Developments and Future Plans
  • 2.8 Lonza
    • 2.8.1 Lonza Details
    • 2.8.2 Lonza Major Business
    • 2.8.3 Lonza Mammalian Cell Line Development Product and Solutions
    • 2.8.4 Lonza Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Lonza Recent Developments and Future Plans
  • 2.9 Abzena
    • 2.9.1 Abzena Details
    • 2.9.2 Abzena Major Business
    • 2.9.3 Abzena Mammalian Cell Line Development Product and Solutions
    • 2.9.4 Abzena Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Abzena Recent Developments and Future Plans
  • 2.10 FUJIFILM Diosynth Biotechnologies
    • 2.10.1 FUJIFILM Diosynth Biotechnologies Details
    • 2.10.2 FUJIFILM Diosynth Biotechnologies Major Business
    • 2.10.3 FUJIFILM Diosynth Biotechnologies Mammalian Cell Line Development Product and Solutions
    • 2.10.4 FUJIFILM Diosynth Biotechnologies Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
  • 2.11 Hera
    • 2.11.1 Hera Details
    • 2.11.2 Hera Major Business
    • 2.11.3 Hera Mammalian Cell Line Development Product and Solutions
    • 2.11.4 Hera Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Hera Recent Developments and Future Plans
  • 2.12 WuXi Biologics
    • 2.12.1 WuXi Biologics Details
    • 2.12.2 WuXi Biologics Major Business
    • 2.12.3 WuXi Biologics Mammalian Cell Line Development Product and Solutions
    • 2.12.4 WuXi Biologics Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 WuXi Biologics Recent Developments and Future Plans
  • 2.13 Danaher
    • 2.13.1 Danaher Details
    • 2.13.2 Danaher Major Business
    • 2.13.3 Danaher Mammalian Cell Line Development Product and Solutions
    • 2.13.4 Danaher Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Danaher Recent Developments and Future Plans
  • 2.14 Northway Biotech
    • 2.14.1 Northway Biotech Details
    • 2.14.2 Northway Biotech Major Business
    • 2.14.3 Northway Biotech Mammalian Cell Line Development Product and Solutions
    • 2.14.4 Northway Biotech Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Northway Biotech Recent Developments and Future Plans
  • 2.15 Sartorius
    • 2.15.1 Sartorius Details
    • 2.15.2 Sartorius Major Business
    • 2.15.3 Sartorius Mammalian Cell Line Development Product and Solutions
    • 2.15.4 Sartorius Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Sartorius Recent Developments and Future Plans
  • 2.16 EirGenix
    • 2.16.1 EirGenix Details
    • 2.16.2 EirGenix Major Business
    • 2.16.3 EirGenix Mammalian Cell Line Development Product and Solutions
    • 2.16.4 EirGenix Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 EirGenix Recent Developments and Future Plans
  • 2.17 Tanvex
    • 2.17.1 Tanvex Details
    • 2.17.2 Tanvex Major Business
    • 2.17.3 Tanvex Mammalian Cell Line Development Product and Solutions
    • 2.17.4 Tanvex Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Tanvex Recent Developments and Future Plans
  • 2.18 Menarini Biotech
    • 2.18.1 Menarini Biotech Details
    • 2.18.2 Menarini Biotech Major Business
    • 2.18.3 Menarini Biotech Mammalian Cell Line Development Product and Solutions
    • 2.18.4 Menarini Biotech Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 Menarini Biotech Recent Developments and Future Plans
  • 2.19 FyoniBio
    • 2.19.1 FyoniBio Details
    • 2.19.2 FyoniBio Major Business
    • 2.19.3 FyoniBio Mammalian Cell Line Development Product and Solutions
    • 2.19.4 FyoniBio Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.19.5 FyoniBio Recent Developments and Future Plans
  • 2.20 Creative Biogene
    • 2.20.1 Creative Biogene Details
    • 2.20.2 Creative Biogene Major Business
    • 2.20.3 Creative Biogene Mammalian Cell Line Development Product and Solutions
    • 2.20.4 Creative Biogene Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.20.5 Creative Biogene Recent Developments and Future Plans
  • 2.21 Rodon Biologics
    • 2.21.1 Rodon Biologics Details
    • 2.21.2 Rodon Biologics Major Business
    • 2.21.3 Rodon Biologics Mammalian Cell Line Development Product and Solutions
    • 2.21.4 Rodon Biologics Mammalian Cell Line Development Revenue, Gross Margin and Market Share (2020-2025)
    • 2.21.5 Rodon Biologics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Mammalian Cell Line Development Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Mammalian Cell Line Development by Company Revenue
    • 3.2.2 Top 3 Mammalian Cell Line Development Players Market Share in 2024
    • 3.2.3 Top 6 Mammalian Cell Line Development Players Market Share in 2024
  • 3.3 Mammalian Cell Line Development Market: Overall Company Footprint Analysis
    • 3.3.1 Mammalian Cell Line Development Market: Region Footprint
    • 3.3.2 Mammalian Cell Line Development Market: Company Product Type Footprint
    • 3.3.3 Mammalian Cell Line Development Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Mammalian Cell Line Development Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Mammalian Cell Line Development Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Mammalian Cell Line Development Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Mammalian Cell Line Development Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Mammalian Cell Line Development Consumption Value by Type (2020-2031)
  • 6.2 North America Mammalian Cell Line Development Market Size by Application (2020-2031)
  • 6.3 North America Mammalian Cell Line Development Market Size by Country
    • 6.3.1 North America Mammalian Cell Line Development Consumption Value by Country (2020-2031)
    • 6.3.2 United States Mammalian Cell Line Development Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Mammalian Cell Line Development Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Mammalian Cell Line Development Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Mammalian Cell Line Development Consumption Value by Type (2020-2031)
  • 7.2 Europe Mammalian Cell Line Development Consumption Value by Application (2020-2031)
  • 7.3 Europe Mammalian Cell Line Development Market Size by Country
    • 7.3.1 Europe Mammalian Cell Line Development Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Mammalian Cell Line Development Market Size and Forecast (2020-2031)
    • 7.3.3 France Mammalian Cell Line Development Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Mammalian Cell Line Development Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Mammalian Cell Line Development Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Mammalian Cell Line Development Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Mammalian Cell Line Development Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Mammalian Cell Line Development Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Mammalian Cell Line Development Market Size by Region
    • 8.3.1 Asia-Pacific Mammalian Cell Line Development Consumption Value by Region (2020-2031)
    • 8.3.2 China Mammalian Cell Line Development Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Mammalian Cell Line Development Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Mammalian Cell Line Development Market Size and Forecast (2020-2031)
    • 8.3.5 India Mammalian Cell Line Development Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Mammalian Cell Line Development Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Mammalian Cell Line Development Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Mammalian Cell Line Development Consumption Value by Type (2020-2031)
  • 9.2 South America Mammalian Cell Line Development Consumption Value by Application (2020-2031)
  • 9.3 South America Mammalian Cell Line Development Market Size by Country
    • 9.3.1 South America Mammalian Cell Line Development Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Mammalian Cell Line Development Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Mammalian Cell Line Development Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Mammalian Cell Line Development Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Mammalian Cell Line Development Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Mammalian Cell Line Development Market Size by Country
    • 10.3.1 Middle East & Africa Mammalian Cell Line Development Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Mammalian Cell Line Development Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Mammalian Cell Line Development Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Mammalian Cell Line Development Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Mammalian Cell Line Development Market Drivers
  • 11.2 Mammalian Cell Line Development Market Restraints
  • 11.3 Mammalian Cell Line Development Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Mammalian Cell Line Development Industry Chain
  • 12.2 Mammalian Cell Line Development Upstream Analysis
  • 12.3 Mammalian Cell Line Development Midstream Analysis
  • 12.4 Mammalian Cell Line Development Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Mammalian Cell Line Development. Industry analysis & Market Report on Mammalian Cell Line Development is a syndicated market report, published as Global Mammalian Cell Line Development Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Mammalian Cell Line Development market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo